Breaking News Instant updates and real-time market news.

TRIP

TripAdvisor

$40.72

0.84 (2.11%)

, CTL

CenturyLink

$19.30

1.72 (9.78%)

09:55
02/15/18
02/15
09:55
02/15/18
09:55

Early notable gainers among liquid option names on February 15th

Notable gainers among liquid option names this morning include TripAdvisor (TRIP) $46.20 +5.47, CenturyLink (CTL) $18.70 +1.11, Frontier Communications (FTR) $8.64 +0.41, Cisco (CSCO) $43.98 +1.88, and Mallinckrodt (MNK) $16.68 +0.52.

TRIP

TripAdvisor

$40.72

0.84 (2.11%)

CTL

CenturyLink

$19.30

1.72 (9.78%)

FTR

Frontier Communications

$8.23

0.33 (4.18%)

CSCO

Cisco

$42.09

0.86 (2.09%)

MNK

Mallinckrodt

$16.58

0.43 (2.66%)

  • 15

    Feb

  • 15

    Feb

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 08

    Mar

  • 13

    Mar

  • 13

    Mar

  • 29

    Mar

TRIP TripAdvisor
$40.72

0.84 (2.11%)

02/15/18
PIPR
02/15/18
NO CHANGE
Target $47
PIPR
Neutral
TripAdvisor price target raised to $47 from $40 at Piper Jaffray
Piper Jaffray analyst Michael Olson raised his price target for TripAdvisor to $47 saying the company last night reported "strong" results with revenue and EBITDA above consensus. TripAdvisor guided to flat year-over-year EBITDA, which is favorable when compared to consensus at down 5.5%, Olson tells investors in a post-earnings research note. He maintains a Neutral rating on the shares.
02/15/18
JEFF
02/15/18
NO CHANGE
Target $27
JEFF
Underperform
TripAdvisor core business is declining, valuation looks rich, says Jefferies
In a post-earnings research note titled "Stay Clear of This Trip," Jefferies analyst Brent Thill says TripAdvisor last night reported a mixed quarter with revenue and adjusted EBITDA above consensus and operating earnings short of expectations on higher taxes. The analyst sees "much better alternatives" among the online travel agencies with TripAdvisor's core business declining and its stock trading at 15 times 2018 EBITDA estimates. Thill says the valuation "looks rich" and keeps an Underperform rating on TripAdvisor with a $27 price target.
01/02/18
BOFA
01/02/18
NO CHANGE
BOFA
BofA/Merrill's Top 10 US Ideas for Q1 2018
BofA/Merrill named its Top 10 Ideas for Q1 2018. They are Buy rated AMD (AMD), Disney (DIS), Exact Sciences (EXAS), Exelon (EXC), lululemon (LULU), PayPal (PYPL), United Rentals (URI), and Walmart (WMT), and Underperform rated L Brands (LB) and TripAdvisor (TRIP).
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
CTL CenturyLink
$19.30

1.72 (9.78%)

01/25/18
01/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Grainger (GWW) upgraded to Outperform from Neutral at Baird with analyst David Manthey saying its strategic initiatives are gaining traction faster than expected. 2. Carter's (CRI) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying his store work and industry reads give him confidence that Carter's comps should come in above plan. 3. CenturyLink (CTL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Jonathan Atkin saying there is potential upside to the company's synergy targets, adding that he believes the new management can restructure operations to generate EBITDA growth. 4. Lowe's (LOW), Dick's Sporting (DKS), and Michaels (MIK) were upgraded to Outperform from Market Perform at Telsey Advisory. 5. Varian Medical (VAR) upgraded to Outperform from Market Perform at Barrington with analyst Michael Petusky saying he views the company's first quarter results as "strong" and believes the outlook for 2018 is likely conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/18
02/14/18
UPGRADE
Target $9

Outperform
Calix upgraded to Outperform with $9 price target at Northland
As previously reported, Northland analyst Tim Savageaux upgraded Calix (CALX) to Outperform from Market Perform, stating that while its Q4 results missed expectations the company looks to have meaningfully addressed its operating expense and gross margin issues. While he expects slower growth as a ramp at Verizon (VZ) offsets weakness at CenturyLink (CTL), he estimates the company will turn from a loss to "solid profits" in FY18, Savageaux tells investors. He set a $9 price target on Calix shares.
02/15/18
MSCO
02/15/18
NO CHANGE
Target $21.6
MSCO
Overweight
CenturyLink results, guidance enough for relief rally, says Morgan Stanley
Morgan Stanley analyst Simon Flannery called CenturyLink's Q4 results and 2018 guidance "messy," but he also believes they provide enough fuel to de-risk the stock in the near-term and drive a relief rally. Management reiterated confidence in the dividend payout, noted prospects for significant margin expansion and expects steady deleveraging helped by recent tax reform, noted Flannery, who has an Overweight rating and $21.60 price target on CenturyLink shares.
02/15/18
JEFF
02/15/18
NO CHANGE
Target $17
JEFF
Hold
CenturyLink results generally in-line excluding items, says Jefferies
Jefferies analyst Scott Goldman says CenturyLink's were messy as expected given the mid-quarter Level 3 acquisition closing. Excluding one-time items, the results were generally in-line, as was the guidance, Goldman tells investors in a post-earnings research note titled "A Satisfying Guide, Though Don't be Fooled by the Headlines." He expects the stock to react positively today given the "considerable apprehension" ahead of the guidance. The analyst leaves quarter "slightly more positive" on CenturyLink but keeps a Hold rating on the name with a $17 price target.
FTR Frontier Communications
$8.23

0.33 (4.18%)

11/10/17
11/10/17
DOWNGRADE
Target $4

Underperform
Frontier Communications downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst David Barden downgraded Frontier Communications to Underperform and slashed its price target to $4 from $19 due to dividend concerns. Barden said Frontier is evaluating the dividend quarter to quarter, while trying to reduce net leverage, and cannot assume with certainty that the dividends will get paid.
12/15/17
12/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Simon Flannery started ViaSat (VSAT) with an Equal Weight rating and $78 price target. 2. Cantor Fitzgerald analyst Elemer Piros initiated Rigel Pharmaceuticals (RIGL) with an Overweight rating and $6 price target, sayign the company is poised to achieve FDA approval of fostamatinib for lead indication immune thrombocytopenia. 3. Exelon (EXC) analyst Paul Fremont initiated Exelon with an Underperform and $36 price target to reflect expected earnings pressure from weak forward gas and power prices and high debt. 4. Credit Suisse analyst Gregory Lewis started Ocean Rig UDW (ORIG) with an Outperform rating and $32 price target, stating that the company's restructuring wiped away $3.3B in debt. 5. Barclays analyst Amir Rozwadowski started Frontier Communications (FTR) with an Underweight rating and $7 price target, as he believes the company's dividend is at risk of being cut further over the near term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/15/17
LEHM
12/15/17
INITIATION
Target $7
LEHM
Underweight
Frontier Communications initiated with an Underweight at Barclays
Barclays analyst Amir Rozwadowski started Frontier Communications with an Underweight rating and $7 price target. The analyst believes the company's dividend is at risk of being cut further over the near term.
12/13/17
MSCO
12/13/17
NO CHANGE
Target $21.6
MSCO
Overweight
Morgan Stanley says CenturyLink can outperform after industry's challenging 2017
Noting that 2017 was a challenging year for wireline telecom and that CenturyLink struggled to hit guidance for the third consecutive year, Simon Flannery still believes that the Level 3 merger is transformative and contends that CenturyLink's (CTL) valuation should ultimately diverge from legacy wireline peers such as Frontier (FTR) and Windstream (WIN) if the deal proves successful. If 2017 marks the trough in operational performance, CenturyLink is poised to outperform "meaningfully" next year and beyond, said Flannery, who trimmed his price target on the stock to $21.60 from $26 but maintains an Overweight rating on the shares.
CSCO Cisco
$42.09

0.86 (2.09%)

02/15/18
COWN
02/15/18
NO CHANGE
Target $51
COWN
Outperform
Cisco price target raised to $51 from $42 at Cowen
Cowen analyst Paul Silverstein raised his price target on Cisco to $51 from $42 as the Q2 results reinforced his investment thesis. He said the return to growth has arrived and was broad-based. Silverstein, who also called the company's stock buyback and increased dividend impressive, reiterated his Outperform rating on Cisco shares.
02/15/18
JEFF
02/15/18
NO CHANGE
Target $48
JEFF
Buy
Cisco shares should continue to re-rate higher, says Jefferies
Jefferies analyst George Notter believes shares of Cisco Systems should continue to re-rate higher, "even from here." Last night's results, guidance, and the narrative around the business were "excellent," Notter tells investors in a pos-earnings research note. He raised his price target for the shares to $48 from $40 and continues to like the risk/reward at current levels. The analyst keeps a Buy rating on Cisco.
02/15/18
RBCM
02/15/18
NO CHANGE
Target $50
RBCM
Outperform
Cisco price target raised to $50 from $44 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on Cisco to $50 after a Q2 beat on earnings and gross margins along with much higher than expected outlook for Q3 revenue growth. Steves believes the stock has more room to run, particularly given that Q3 should have the most difficult comparisons for growth in switching. The analyst also believes that the increase in stock buyback and dividend will attract more defensively-minded investors, keeping his Outperform rating.
02/15/18
MKMP
02/15/18
NO CHANGE
Target $48
MKMP
Neutral
Cisco price target raised to $48 from $38 at MKM Partners
MKM Partners analyst Michael Genovese raised his price target on Cisco to $48 after its Q2 results, saying the company posted a clean beat with growth in all major reporting segments, including infrastructure. Genovese points to product order growth of 5%, up from 1% in the prior quarter, allowing for Q3 revenue growth outlook of 3%-5% that's above his view of 1.5%. The analyst keeps his Neutral rating on Cisco despite the good quarter, noting "weak secular Routing trends in the Service Provider market" and soft performance in "more sophisticated large Enterprise customer".
MNK Mallinckrodt
$16.58

0.43 (2.66%)

02/02/18
LEHM
02/02/18
DOWNGRADE
Target $20
LEHM
Underweight
Mallinckrodt downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao downgraded Mallinckrodt to Underweight and cut his price target for the shares to $20 from $23. The acquisition of Sucampo (SCMP) does not address ongoing concern over Acthar and reduces the company's strategic options by raising leverage to 4.5 times, Tsao tells investors in a research note. Reimbursement pressure for Acthar could intensify, and, while not imminent, the franchise could face competition, the analyst adds.
01/05/18
UBSW
01/05/18
DOWNGRADE
Target $18
UBSW
Neutral
Sucampo downgraded to Neutral from Buy at UBS
UBS analyst Marc Goodman downgraded Sucampo Pharmaceuticals (SCMP) to Neutral to reflect the takeover by Mallinckrodt (MNK). The analyst believes the deal is likely to close without significant issues and upped his price target for the shares to $18 from $15.
01/08/18
WELS
01/08/18
NO CHANGE
WELS
Market Perform
Mallinckrodt news likely to viewed as slight negative, says Wells Fargo
Wells Fargo analyst David Maris believes Mallinckrodt's sale today of two hemostasis products will likely be viewed as slightly negative since it is dilutive and reverses a prior deal. At the time of the original acquisition, Mallinckrodt said it was strategically expanding its hospital presence and cited the innovative profiles, high growth potential, and durability of Recothrom and Preveleak, Maris tells investors in a research note. He keeps a Market Perform on the shares.
01/09/18
BMOC
01/09/18
NO CHANGE
BMOC
Outperform
BMO Capital 'pleased' with Mallinckrodt steps to evolve portfolio
After Mallinckrodt (MNK) announced the divestiture of hemostasis products Recothrom and Preveleak to Baxter (BAX) for $185M, BMO Capital analyst Gary Nachman said he was "pleased" with these moves and the company's recent deal for Sucampo (SCMP) as steps toward evolving its portfolio and reducing Acthar concentration risk. While saying there is still more to do, Nachman believes Mallinckrodt's expanding pipeline warrants more attention and he keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

EQH

AXA Equitable

$20.84

-0.565 (-2.64%)

19:12
03/20/19
03/20
19:12
03/20/19
19:12
Syndicate
AXA Equitable 40M share Secondary priced at $20.50 »

JPMorgan, Morgan Stanley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

OTTW

Ottawa Bancorp

$13.56

-0.14 (-1.02%)

19:02
03/20/19
03/20
19:02
03/20/19
19:02
Hot Stocks
Ottawa Bancorp declares special dividend of 35c per share »

The special dividend will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAZZ

Jazz Pharmaceuticals

$133.73

-1.74 (-1.28%)

18:57
03/20/19
03/20
18:57
03/20/19
18:57
Hot Stocks
Jazz Pharmaceuticals' Sunosi for excessive daytime sleepiness approved by FDA »

Jazz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

AYI

Acuity Brands

$123.00

-5.53 (-4.30%)

18:52
03/20/19
03/20
18:52
03/20/19
18:52
Upgrade
Acuity Brands rating change  »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

HYAC

Haymaker Acquisition

$11.79

(0.00%)

, OSW

OneSpaWorld

$0.00

(0.00%)

18:47
03/20/19
03/20
18:47
03/20/19
18:47
Hot Stocks
OneSpaWorld says will start trading on Nasdaq March 21 »

OneSpaWorld Holdings…

HYAC

Haymaker Acquisition

$11.79

(0.00%)

OSW

OneSpaWorld

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

, MU

Micron

$40.08

-0.3 (-0.74%)

18:46
03/20/19
03/20
18:46
03/20/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

MLHR

Herman Miller

$35.07

-0.85 (-2.37%)

MU

Micron

$40.08

-0.3 (-0.74%)

WSM

Williams-Sonoma

$56.88

0.09 (0.16%)

SIEN

Sientra

$9.76

0.945 (10.73%)

EB

Eventbrite

$20.09

-0.72 (-3.46%)

GES

Guess

$22.10

-0.41 (-1.82%)

UNIT

Uniti Group

$10.01

0.15 (1.52%)

WEX

Wex

$184.85

-1.465 (-0.79%)

CBMG

Cellular Biomedicine

$18.26

0.38 (2.13%)

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

  • 21

    Mar

  • 21

    Mar

SAGE

Sage Therapeutics

$152.62

-3.46 (-2.22%)

18:39
03/20/19
03/20
18:39
03/20/19
18:39
Hot Stocks
Sage Therapeutics CEO: Postpartum depression is a medical issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$174.38

-1.39 (-0.79%)

18:27
03/20/19
03/20
18:27
03/20/19
18:27
Recommendations
Nvidia analyst commentary at Tigress Financial »

Nvidia to overcome…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$56.17

-0.93 (-1.63%)

18:24
03/20/19
03/20
18:24
03/20/19
18:24
Periodicals
CVS to start selling CBD products in partnership with Curaleaf, Bloomberg says »

Curaleaf (CURLF) said…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$56.17

-0.93 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

PETQ

PetIQ

$29.87

0.91 (3.14%)

18:23
03/20/19
03/20
18:23
03/20/19
18:23
Hot Stocks
PetIQ CEO: We are totally transparent about our price model »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

T

AT&T

$30.51

-0.19 (-0.62%)

18:21
03/20/19
03/20
18:21
03/20/19
18:21
Periodicals
AT&T CEO: Huawei makes it hard for carriers to shift suppliers, Reuters says »

AT&T CEO Randall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 07

    May

  • 20

    May

SGSOY

SGS SA

$0.00

(0.00%)

18:19
03/20/19
03/20
18:19
03/20/19
18:19
Downgrade
SGS SA rating change  »

SGS SA downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$155.94

-0.93 (-0.59%)

, RBGLY

Reckitt Benckiser

$0.00

(0.00%)

18:16
03/20/19
03/20
18:16
03/20/19
18:16
Hot Stocks
Clorox files false advertising lawsuit against Reckitt Benckiser »

The Clorox Company (CLX)…

CLX

Clorox

$155.94

-0.93 (-0.59%)

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

BA

Boeing

$376.41

2.54 (0.68%)

18:09
03/20/19
03/20
18:09
03/20/19
18:09
Periodicals
Boeing pushes flight test to International Space Station to August, Reuters says »

Boeing has postponed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

CE

Celanese

$101.04

0.08 (0.08%)

18:02
03/20/19
03/20
18:02
03/20/19
18:02
Hot Stocks
Celanese increases acetyl intermeditates prices »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

FTDR

Frontdoor

$32.10

-2.29 (-6.66%)

17:58
03/20/19
03/20
17:58
03/20/19
17:58
Syndicate
Frontdoor 16.73M share Secondary priced at $30.00 »

JPMorgan and Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

LEVI

Levi Strauss

$0.00

(0.00%)

17:57
03/20/19
03/20
17:57
03/20/19
17:57
Syndicate
Levi Strauss 36.667M share IPO priced at $17.00 »

The deal priced above its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

17:55
03/20/19
03/20
17:55
03/20/19
17:55
Conference/Events
William Blair healthcare/biotech analysts to hold a dinner meeting »

Analysts meet with…

JBLU

JetBlue

$16.31

-0.32 (-1.92%)

17:50
03/20/19
03/20
17:50
03/20/19
17:50
Periodicals
Suit: JetBlue pilots sexually assaulted female airline workers, NY Post says »

According to a report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.14

1.57 (0.84%)

, NWS

News Corp

$12.64

0.02 (0.16%)

17:50
03/20/19
03/20
17:50
03/20/19
17:50
Periodicals
Apple reaches deal with WSJ over Apple News service, 9to5Mac says »

Apple (AAPL) has made a…

AAPL

Apple

$188.14

1.57 (0.84%)

NWS

News Corp

$12.64

0.02 (0.16%)

NWSA

News Corp.

$12.61

0.07 (0.56%)

NYT

New York Times

$33.36

-0.62 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

MAR

Marriott

$123.65

-2.09 (-1.66%)

, CVS

CVS Health

$56.17

-0.93 (-1.63%)

17:47
03/20/19
03/20
17:47
03/20/19
17:47
Hot Stocks
Marriott appoints Margaret McCarthy to Board of Directors »

The Board of Directors of…

MAR

Marriott

$123.65

-2.09 (-1.66%)

CVS

CVS Health

$56.17

-0.93 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Apr

BA

Boeing

$376.41

2.54 (0.68%)

17:28
03/20/19
03/20
17:28
03/20/19
17:28
Hot Stocks
Boeing awarded $4.04B Navy contract modification for delivery of 78 F/A-18s »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

WOR

Worthington

$36.81

-0.175 (-0.47%)

17:24
03/20/19
03/20
17:24
03/20/19
17:24
Hot Stocks
Worthington announces additional 6.6M share repurchase plan »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

MU

Micron

$40.08

-0.3 (-0.74%)

17:24
03/20/19
03/20
17:24
03/20/19
17:24
Hot Stocks
Micron says it is idling DRAM capacity »

Says wants to bring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    May

T

AT&T

$30.51

-0.19 (-0.62%)

, CMCSA

Comcast

$39.48

-0.35 (-0.88%)

17:21
03/20/19
03/20
17:21
03/20/19
17:21
Periodicals
AT&T, Comcast partnering to fight robocalls, Verge says »

AT&T (T) and Comcast…

T

AT&T

$30.51

-0.19 (-0.62%)

CMCSA

Comcast

$39.48

-0.35 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 07

    May

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.